KpATCC43816 Protein target profile

thioredoxin-disulfide reductase

Accession: VK055_1566

Gene: AIK80186.1 trxB 3D evidence: AlphaFold DB model + ColabFold model Metabolism 1 reaction UniProt A0A0H3GQX9
Length 322
Pocket druggability (P2Rank · AlphaFold DB model) 0.85
Metabolic reactions 1
Chokepoint No
Direct ligand evidence 0 71 total records
Functional annotation 1 EC 7 GO
Target summary

Strong target candidate with converging metabolic, structural and chemical evidence.

Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.

Terms and data sources used on this page

PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.

AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.

ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.

pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.

FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.

Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.

PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.

ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.

ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.

LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.

Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.

DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.

Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.

EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.

KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.

Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.

Prioritization evidence

Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.

Off-target risk

Human off-target
No hit
Gut microbiome similarity
12.4% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.

Essentiality

Essential (DEG)
Y
DEG identity (%)
84.639 Higher values support similarity to known essential genes.
DEG E-value
0.0 Smaller values mean stronger essential-gene similarity.

Structure confidence

ColabFold pLDDT
94.79 0-100 confidence; >70 supports local structural interpretation.

Binding-site evidence

AlphaFold DB / UniProt model

P2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.

Druggability (P2Rank) 0.85
Structure A0A0H3GQX9
Pocket Pocket 1
Druggability (FPocket) 0.892
Structure A0A0H3GQX9
Pocket Pocket 2
ColabFold model
P2Rank 0.885 · Pocket 1
FPocket 0.578 · Pocket 1
Core conservation Conserved core gene
Roary core
CoreCruncher core
Gut microbiome 590 / 4744 genomes with a hit
Prevalence 12.4%

Metabolic context

Reactions catalyzed, pathway membership, and centrality in the genome-scale metabolic network.

Explore metabolic network

Metabolic context: more central than 98.9% of genes in this genome, no human homolog detected.

Relative network centrality 98.9% more central than 98.9% of genes in this genome
Chokepoint Not a chokepoint
Pathways

No specific KEGG pathway assigned - this reaction either has no KEGG mapping, or only matches a generic overview map with no route-level information.

Catalyzed reaction

1 reaction mapped to this gene in the metabolic model. Open the full network to see each one, with substrates/products and the reaction-reaction map.

Imported from KpATCC43816.sbml · 2026-07-09

Sequence

Primary amino-acid sequence viewer.

MGTAKHSKLLILGSGPAGYTAAVYAARANLQPVLITGMEKGGQLTTTTEVENWPGDPNDLTGPLLMERMHEHAAKFETEIIFDHISRVDLQNRPFRLTGDSGEYTCDALIIATGASARYLGLPSEEAFKGRGVSACATCDGFFYRNQKVAVIGGGNTAVEEALYLSNIASEVHLIHRRDSFRAEKILIKRLMDKVASGNIVLHTDRTLEEVTGDQMGVSGLRLRDTKNSDNVESLEVAGLFVAIGHSPNTAIFEGQLELENGYIKVQSGIHGNATQTSISGVFAAGDVMDHIYRQAITSAGTGCMAALDAERYLDGLADACK

Functional annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 7 GO

Subcellular localization

Localization
Unknown

Enzyme Commission (EC)

1

Gene Ontology (GO)

7
  • GO:0004791 Catalysis of the reaction: thioredoxin-dithiol + NADP+ = thioredoxin-disulfide + H+ + NADPH.
  • GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
  • GO:0019430 Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2).
  • GO:0005737 The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
  • GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
  • GO:0032991 A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
  • GO:0050660 Binding to FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.

Sequence domains and features

Domain and signature matches imported from InterPro and related databases.

33 records
Show feature table
Start End DB Term Name
5 315 PANTHER PTHR48105 THIOREDOXIN REDUCTASE 1-RELATED-RELATED
8 300 Pfam PF07992 Pyridine nucleotide-disulphide oxidoreductase
8 300 InterPro IPR023753 FAD/NAD(P)-binding domain
1 25 Phobius SIGNAL_PEPTIDE Signal peptide region
106 124 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
9 28 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
267 289 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
237 253 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
148 166 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
26 322 Phobius NON_CYTOPLASMIC_DOMAIN Region of a membrane-bound protein predicted to be outside the membrane, in the extracellular region.
8 314 NCBIfam TIGR01292 thioredoxin-disulfide reductase
8 314 InterPro IPR005982 Thioredoxin reductase
136 156 ProSitePatterns PS00573 Pyridine nucleotide-disulphide oxidoreductases class-II active site.
136 156 InterPro IPR008255 Pyridine nucleotide-disulphide oxidoreductase, class-II, active site
3 315 SUPERFAMILY SSF51905 FAD/NAD(P)-binding domain
3 315 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
8 30 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
129 141 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
62 72 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
277 295 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
239 260 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
107 115 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
41 56 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
199 215 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
144 168 PRINTS PR00469 Pyridine nucleotide disulphide reductase class-II signature
118 245 Gene3D G3DSA:3.50.50.60 -
118 245 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
118 245 FunFam G3DSA:3.50.50.60:FF:000007 Alkyl hydroperoxide reductase, F subunit
9 17 Phobius SIGNAL_PEPTIDE_H_REGION Hydrophobic region of a signal peptide.
9 314 Gene3D G3DSA:3.50.50.60 -
9 314 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
1 8 Phobius SIGNAL_PEPTIDE_N_REGION N-terminal region of a signal peptide.
18 25 Phobius SIGNAL_PEPTIDE_C_REGION C-terminal region of a signal peptide.

3D structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.

Download VMD script Full viewer

Loading 3D structure...

Drag to rotate — click the view, then scroll to zoom.

Pocket score High Medium Low
How colors and pocket overlays are used
Uniform protein color marks the displayed model as a single molecular object.
Experimental PDB structures may be colored by chain to distinguish subunits or copies present in the file.
Pocket colors and alpha spheres are evidence overlays for predicted binding cavities; they are not alternative protein chains.
'Alpha spheres' is FPocket's own cavity-shape geometry, imported when available and aligned with the loaded structure.
'Pocket atoms'/'Predicted site atoms' show the pocket's residue atoms instead: P2Rank reports residues rather than alpha spheres, and FPocket falls back to this when alpha-sphere geometry is unavailable or doesn't align.
'No pocket geometry' means neither alpha spheres nor residue-position data could be found for that pocket; the layer just highlights the same residues as 'Nearby residues'.
Pocket details Inspect a specific pocket, or open the full viewer

Binding pockets · P2Rank

Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2

Pocket 1 P2Rank #1
0.85
Show in viewer
Surrounding area
Pocket 2 P2Rank #2
0.584
Likely same site as FPocket 2 2.4 Å 19 shared residues 79% of smaller site
Show in viewer
Surrounding area
Pocket 3 P2Rank #3
0.496
Likely same site as FPocket 18 4.9 Å 12 shared residues 80% of smaller site
Show in viewer
Surrounding area
Pocket 4 P2Rank #4
0.124
Likely same site as FPocket 3 1.4 Å 9 shared residues 90% of smaller site
Show in viewer
Surrounding area
Pocket 5 P2Rank #5
0.084
Show in viewer
Surrounding area

Binding pockets · FPocket

Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4

Pocket 1 FPocket #2
0.892 Unusual size
Likely same site as P2Rank 2 2.4 Å 19 shared residues 79% of smaller site
Show in viewer
Surrounding area
Pocket 2 FPocket #3
0.359
Likely same site as P2Rank 4 1.4 Å 9 shared residues 90% of smaller site
Show in viewer
Surrounding area
Pocket 3 FPocket #18
0.357
Likely same site as P2Rank 3 4.9 Å 12 shared residues 80% of smaller site
Show in viewer
Surrounding area
All structural evidence 0 experimental · 2 predicted

Structural evidence

0 + 2

Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold DB AF_A0A0H3GQX9
AlphaFold DB full sequence Viewing
ColabFold VK055_1566
ColabFold full sequence Loaded

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

71 records
Chemistry signal

Structural and bioactivity evidence are both available for this target.

Direct evidence 0 same-protein records
Transferred evidence 21 records from similar proteins
Structural ligands 5 0 loaded crystals
Measured bioactivity 16 direct and transferred ChEMBL records
Proposed compounds 50 similarity-based ZINC candidates
Best available ligand signal
3AA PDB via homolog 716.4 Da · LogP -2.42 · TPSA 347.7 Open detail RCSB PDB
FDA PDB via homolog Detail RCSB PDB
FLC PDB via homolog Detail RCSB PDB
MLI PDB via homolog Detail RCSB PDB
MLT PDB via homolog Detail RCSB PDB

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
3AA RCSB PDB P0A9P4 716.4 Da LogP -2.42 TPSA 347.7 3 viol. ✓ Clean c1cc(c[n+](c1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO[P…
FDA RCSB PDB Q8YID2 787.6 Da LogP -1.75 TPSA 363.3 3 viol. ✓ Clean Cc1cc2c(cc1C)N(C3=C(N2)C(=O)NC(=O)N3)C[C@@H]([C…
FLC RCSB PDB A9LN30 189.1 Da LogP -5.25 TPSA 140.6 ✓ Ro5 ✓ Clean C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
MLI RCSB PDB A0A229Y1X4 102.0 Da LogP -3.12 TPSA 80.3 ✓ Ro5 ✓ Clean C(C(=O)[O-])C(=O)[O-]
MLT RCSB PDB A0A229Y1X4 134.1 Da LogP -1.09 TPSA 94.8 ✓ Ro5 ✓ Clean C([C@H](C(=O)O)O)C(=O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.

Cross-references

External database identifiers for this protein, its structures, ligands, and metabolic reactions.